Marimed (MRMD) Net Equity Issued and Repurchased (2016 - 2019)
Marimed (MRMD) posted quarterly Net Equity Issued and Repurchased of $150000.0 for Q4 2019, down 98.99% year-over-year from $14.9 million in Q4 2018, and down 94.23% quarter-over-quarter from $2.6 million in Q1 2019.
Marimed (MRMD) Net Equity Issued and Repurchased (2016 - 2019) Analysis & Trends
Marimed (MRMD) has reported Net Equity Issued and Repurchased for 4 consecutive years, with $150000.0 the latest figure, recorded in Q4 2019.
- In Q4 2019, Net Equity Issued and Repurchased fell 98.99% year-over-year to $150000.0; the TTM figure through Dec 2019 stood at $17.7 million (down 44.45% YoY), while the FY2019 annual figure was $2.8 million, down 91.36% from the prior year.
- Net Equity Issued and Repurchased slipped to $150000.0 in Q4 2019 per MRMD's latest filing, from $2.6 million in the prior quarter.
- Across five years, Net Equity Issued and Repurchased topped out at $14.9 million in Q4 2018 and bottomed at -$50000.0 in Q3 2017.
- Historically, Net Equity Issued and Repurchased has averaged $3.8 million across 4 years, with a median of $1.4 million in 2017.
- Annual changes were most pronounced in 2018 — Net Equity Issued and Repurchased soared 16969.99% — and 2019, when it tumbled 98.99%.
- Marimed's Net Equity Issued and Repurchased stood at $200000.0 in 2016, then jumped by 617.9% to $1.4 million in 2017, then soared by 939.49% to $14.9 million in 2018, then sank by 98.99% to $150000.0 in 2019.
- Business Quant data shows MRMD's Net Equity Issued and Repurchased at $150000.0 in Q4 2019, $2.6 million in Q1 2019, and $14.9 million in Q4 2018.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Equity Issued and Repurchased (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.51 Bn | 43.55 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.52 Bn | 39.86 Bn | 2.15 Bn | - |
| 3 | Zoetis | 32.43 Bn | 30.75 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn | - |
| 5 | United Therapeutics | 21.87 Bn | 19.21 Bn | 683.80 Mn | - |
| 6 | Viatris | 18.98 Bn | 18.09 Bn | 1.46 Bn | 700,000.00 |
| 7 | Neurocrine Biosciences | 15.43 Bn | 15.04 Bn | 935.80 Mn | 84.80 Mn |
| 8 | Elanco Animal Health | 12.02 Bn | 11.49 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - | - |
| 10 | Marimed | 33.57 Mn | 25.13 Mn | 16.23 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2019 | 150,000.00 |
| Dec 31, 2019 | 150,000.00 |
| Mar 31, 2019 | 2.60 Mn |
| Mar 31, 2019 | 2.60 Mn |
| Dec 31, 2018 | 14.93 Mn |
| Dec 31, 2018 | 14.93 Mn |
| Sep 30, 2018 | 8.43 Mn |
| Sep 30, 2018 | 8.43 Mn |
| Jun 30, 2018 | 7.86 Mn |
| Jun 30, 2018 | 7.86 Mn |
| Mar 31, 2018 | 600,000.00 |
| Mar 31, 2018 | 600,000.00 |
| Dec 31, 2017 | 1.44 Mn |
| Dec 31, 2017 | 1.44 Mn |
| Sep 30, 2017 | -50,000.00 |
| Sep 30, 2017 | -50,000.00 |
| Jun 30, 2017 | 3.90 Mn |
| Jun 30, 2017 | 3.90 Mn |
| Mar 31, 2017 | 1.30 Mn |
| Mar 31, 2017 | 1.30 Mn |